{"id":19208,"date":"2023-08-07T11:46:58","date_gmt":"2023-08-07T09:46:58","guid":{"rendered":"https:\/\/ggba.swiss\/longevity-start-up-epiterna-raises-eur-10-million-to-slow-ageing-and-extend-lifespan\/"},"modified":"2023-08-07T11:51:05","modified_gmt":"2023-08-07T09:51:05","slug":"epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/","title":{"rendered":"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement et prolonger l&rsquo;esp\u00e9rance de vie"},"content":{"rendered":"\n<p>Fond\u00e9e en 2022 en tant que spin-off du laboratoire d&rsquo;Alejandro Ocampo \u00e0 l&rsquo;Universit\u00e9 de Lausanne, <a href=\"https:\/\/www.epiterna.com\/\">EPITERNA<\/a> a pour mission de donner plus de temps aux animaux de compagnie et aux humains en ralentissant le processus de vieillissement.<\/p>\n\n\n\n<p>Gr\u00e2ce \u00e0 une plateforme unique de criblage de m\u00e9dicaments \u00e0 haut d\u00e9bit, EPITERNA d\u00e9veloppe des produits qui \u00e9valuent l&rsquo;effet des m\u00e9dicaments sur le vieillissement. L&rsquo;entreprise se concentre sur les m\u00e9dicaments et les compos\u00e9s d\u00e9j\u00e0 approuv\u00e9s pour des maladies humaines et animales sp\u00e9cifiques, ce qui rend son approche fond\u00e9e sur la s\u00e9curit\u00e9 et la praticit\u00e9. Gr\u00e2ce \u00e0 des m\u00e9dicaments \u00e0 petites mol\u00e9cules, leurs th\u00e9rapies sont con\u00e7ues pour \u00eatre plus abordables et accessibles au grand public.<\/p>\n\n\n\n<p>La plateforme innovante de la start-up \u00e9value les m\u00e9dicaments au niveau mol\u00e9culaire et cellulaire, en utilisant des mod\u00e8les animaux de r\u00e9f\u00e9rence pour la recherche sur le vieillissement. Elle a d\u00e9j\u00e0 \u00e9valu\u00e9 des centaines de m\u00e9dicaments sur de petits animaux et plus d&rsquo;une douzaine sur de plus gros, identifiant des candidats prometteurs et d\u00e9couvrant de nouvelles pistes.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">De perc\u00e9es scientifiques ambitieuses vers un financement important<\/h4>\n\n\n\n<p>Alejandro Ocampo, cofondateur et CEO d&rsquo;EPITERNA, a consacr\u00e9 15 ans \u00e0 l&rsquo;\u00e9tude du vieillissement. Ses travaux ant\u00e9rieurs comprennent des perc\u00e9es \u00e0 l&rsquo;Institut Salk en Californie, o\u00f9 il a \u00e9t\u00e9 parmi les premiers \u00e0 d\u00e9montrer comment la reprogrammation \u00e9pig\u00e9n\u00e9tique pouvait prolonger la dur\u00e9e de vie chez les souris. La poursuite de ses travaux \u00e0 l&rsquo;<a href=\"https:\/\/www.unil.ch\/index.html\">Universit\u00e9 de Lausanne<\/a> a \u00e9t\u00e9 d\u00e9terminante pour la cr\u00e9ation et le d\u00e9veloppement d&rsquo;EPITERNA.<\/p>\n\n\n\n<p>L&rsquo;entreprise a des projets ambitieux, notamment la r\u00e9alisation d&rsquo;essais cliniques sur des animaux plus grands, tels que des chiens, en 2024 en Europe. Son objectif n&rsquo;est pas seulement de prolonger la vie, mais de cr\u00e9er des vies plus longues, plus saines et plus heureuses, sans maladies li\u00e9es \u00e0 l&rsquo;\u00e2ge.<\/p>\n\n\n\n<p>Ce nouvel investissement de EUR 10 millions arrive \u00e0 un moment crucial pour EPITERNA, permettant \u00e0 la start-up de financer sa croissance et d&rsquo;acc\u00e9l\u00e9rer son d\u00e9veloppement. Le soutien de Prima Materia repr\u00e9sente une reconnaissance importante de la vision et de l&rsquo;approche de l&rsquo;entreprise.<\/p>\n\n\n\n<p>L&rsquo;\u00e9quipe d&rsquo;EPITERNA, compos\u00e9e de 15 employ\u00e9s (scientifiques, ing\u00e9nieurs, v\u00e9t\u00e9rinaires et m\u00e9decins), est sur le point de s&rsquo;agrandir, l&rsquo;entreprise recrutant actuellement pour plusieurs postes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions aupr\u00e8s de Prima Materia, la soci\u00e9t\u00e9 d&rsquo;investissement de Daniel Ek, fondateur de Spotify, et de Shakil Khan, l&rsquo;un des premiers investisseurs de Spotify.<\/p>\n","protected":false},"author":6,"featured_media":19204,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1162,1148,1171,1142],"class_list":["post-19208","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-education-en-fr","tag-financing-fr-2","tag-pharma-fr-2","tag-rd-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement<\/title>\n<meta name=\"description\" content=\"La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions pour ralentir le vieillissement.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement\" \/>\n<meta property=\"og:description\" content=\"La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions pour ralentir le vieillissement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-07T09:46:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-07T09:51:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2360\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement et prolonger l&rsquo;esp\u00e9rance de vie\",\"datePublished\":\"2023-08-07T09:46:58+00:00\",\"dateModified\":\"2023-08-07T09:51:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\"},\"wordCount\":425,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg\",\"keywords\":[\"Biotech\",\"Education\",\"Financing\",\"Pharma\",\"R&amp;D\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\",\"name\":\"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg\",\"datePublished\":\"2023-08-07T09:46:58+00:00\",\"dateModified\":\"2023-08-07T09:51:05+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions pour ralentir le vieillissement.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg\",\"width\":2360,\"height\":1622,\"caption\":\"EPITERNA est sp\u00e9cialis\u00e9e le d\u00e9veloppement de th\u00e9rapies permettant de prolonger la dur\u00e9e de vie en bonne sant\u00e9 des chiens et des chats de compagnie, ainsi que des humains. | \u00a9 EPITERNA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement et prolonger l&#8217;esp\u00e9rance de vie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement","description":"La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions pour ralentir le vieillissement.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/","og_locale":"fr_FR","og_type":"article","og_title":"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement","og_description":"La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions pour ralentir le vieillissement.","og_url":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-08-07T09:46:58+00:00","article_modified_time":"2023-08-07T09:51:05+00:00","og_image":[{"width":2360,"height":1622,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement et prolonger l&rsquo;esp\u00e9rance de vie","datePublished":"2023-08-07T09:46:58+00:00","dateModified":"2023-08-07T09:51:05+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/"},"wordCount":425,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg","keywords":["Biotech","Education","Financing","Pharma","R&amp;D"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/","url":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/","name":"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg","datePublished":"2023-08-07T09:46:58+00:00","dateModified":"2023-08-07T09:51:05+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La start-up vaudoise sp\u00e9cialis\u00e9e dans la long\u00e9vit\u00e9, EPITERNA, a lev\u00e9 EUR 10 millions pour ralentir le vieillissement.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/08\/EPITERNA_2360x1622.jpg","width":2360,"height":1622,"caption":"EPITERNA est sp\u00e9cialis\u00e9e le d\u00e9veloppement de th\u00e9rapies permettant de prolonger la dur\u00e9e de vie en bonne sant\u00e9 des chiens et des chats de compagnie, ainsi que des humains. | \u00a9 EPITERNA"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/epiterna-leve-eur-10-millions-pour-ralentir-le-vieillissement-et-prolonger-lesperance-de-vie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"EPITERNA l\u00e8ve EUR 10 millions pour ralentir le vieillissement et prolonger l&#8217;esp\u00e9rance de vie"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=19208"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19208\/revisions"}],"predecessor-version":[{"id":19212,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/19208\/revisions\/19212"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/19204"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=19208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=19208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=19208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}